Product

DKF-313

Aliases

DKF-313 placebo

1 clinical trial

1 indication

Indication

Benign Prostatic Hyperplasia

Clinical trial

A Multi-center, Randomized, Double-blinded, Double-dummy, Parallel Group, 48-week, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Status: Completed, Estimated PCD: 2023-06-12